Bradley 20 0.02 mg - 3 mg (ethinylestradiol 0,02 mg + drospirenon 3 mg tablet (or.) (I) + placebo tablet (or.) (II)) · CNK 2985281

Product information

Product name
Bradley 20 0.02 mg - 3 mg
Pack
6 x 28 (24 + 4)
Active ingredient
ethinylestradiol 0,02 mg + drospirenon 3 mg tablet (or.) (I) + placebo tablet (or.) (II)
CNK Code
2985281
Availability score
0 / 10
Historic availability score
Locked

Product properties

CAS code
57-63-6
ATC code
G03AA12
Company
Sandoz
Pharmaceutical form
Film-coated tablet
Ex-factory price
Authorisation number
BE426982
GTIN
07613421000707
Delivery mode
M2
Delivery environment
Public
CTI Extended
426982-03

Pharmacist Assessment

Assessment title
Commercialization officially ended — no stock
Assessment description

SAM has flagged this product as commercially stopped (reason: Commercial reasons) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Assessment alternative
Annaïs Continu 0.02 mg - 3 mg (CNK 3326006) — Score: 7.44/10

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives
Parallel import available 1 Magistral alternative available 1

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commercial reasons

Alternative available

Composition

6 ingredients

Ingredients
Substance Type Strength CAS
Substance
Drospirenon
Type
Active ingredient
Strength
3 mg
CAS
67392-87-4
Substance
Ethinylestradiol
Type
Active ingredient
Strength
0.02 mg
CAS
57-63-6
Substance
Lactosemonohydraat
Type
Excipient
Strength
44 mg
CAS
Substance
Polysorbaat 80
Type
Excipient
Strength
0.9 mg
CAS
Substance
Placebo
Type
Active ingredient
Strength
CAS
Substance
Lactose
Type
Excipient
Strength
89.5 mg
CAS

Additional information

Leaflet
Download leaflet
SPC
Download SPC
BCPI
View on BCPI
PharmaStatus
View on PharmaStatus

Availability statistics

Current status
Commercialization stopped
Days unavailable (last year)
413 days
Number of status changes
2
Active supply problems
0
Last change
23/12/2025